2025: UVM Cancer Center and UVM Children's Hospital Offer Promising Pediatric Oncology Trial
From 2019 to 2024, the UVM Cancer Center and UVM Children’s Hospital hosted a trial to investigate whether chemotherapy paired with an immunotherapy treatment could improve outcomes for children diagnosed with standard-risk B-cell acute lymphoblastic leukemia (ALL).
Read more2025: UVM Cancer Center and UVM Children's Hospital Offer Promising Pediatric Oncology Trial
From 2019 to 2024, the UVM Cancer Center and UVM Children’s Hospital hosted a trial to investigate whether chemotherapy paired with an immunotherapy treatment could improve outcomes for children diagnosed with standard-risk B-cell acute lymphoblastic leukemia (ALL).
Read more2025
2024: Novel therapy uncovered at the University of Vermont Cancer Center enters Phase 2 Clinical Study
Since 2017, the Cunniff Lab at the University of Vermont (UVM) Cancer Center with support from industry partner, RS Oncology, has been making significant strides to launch a new therapy for the treatment of mesothelioma.
Read more2024
2023: New Drug Gives Quality-of-Life Boost to Cancer Patients with Deadly Blood Clots
For the five to 25 percent of cancer patients who develop a potentially fatal condition called venous thrombosis, which causes clots to form in the blood that can lodge in the lungs or other vital organs, the anxiety of a cancer diagnosis comes with an unpleasant added chore — the need to...
Read more
2022: Study Finds Exposure to Phthalates May Increase Children's Cancer Risk
In a first-of-its-kind study, research from the University of Vermont Cancer Center has linked phthalates, commonly called the “everywhere chemical,” to higher incidence of specific childhood cancers.
Read more2022: Study Finds Exposure to Phthalates May Increase Children's Cancer Risk
In a first-of-its-kind study, research from the University of Vermont Cancer Center has linked phthalates, commonly called the “everywhere chemical,” to higher incidence of specific childhood cancers.
Read more2022
2021: UVM Invests Holcombe as Inaugural J. Walter Juckett Chair in Cancer Research
With $3 million in support from a longtime major supporter of the University of Vermont Cancer Center, Randall F. Holcombe, M.D., M.B.A., was invested as the inaugural J. Walter Juckett Chair in Cancer Research in the Larner College of Medicine on November 3.
Read more